Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings
March 27, 2024
In this podcast, Dr. Lindsay Bowman, Dr. Olivia Berger, and Dr. Suzanne Nesbit discuss the AJHP Descriptive Report, “Operationalizing the new DEA exception: A novel process for dispensing of methadone for opioid use disorder at discharge from acute care settings,” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
SPEAKERS
Lindsay Bowman, PharmD, BCPS is a graduate of the University of Pittsburgh School of Pharmacy and completed residency training at The Johns Hopkins Hospital (JHH), including a PGY1 Pharmacy residency and a PGY2 in Pain Management and Palliative Care. Dr. Bowman is currently practicing as a Clinical Pharmacy Specialist on the JHH Addiction Consult Service, where she provides medication and pain expertise as part of a multidisciplinary team caring for hospitalized patients with substance use disorders.
Suzanne Nesbit, PharmD, FCCP, FASHP is a Clinical Specialist in Pain Management and Palliative Care with the Department of Pharmacy at The Johns Hopkins Hospital and serves as the Residency Program Director for the PGY2 Pain Management and Palliative Care Residency. In 2018, she was named Co-Chair of The Johns Hopkins Health System Opioid Stewardship Clinical Community. Currently, she is serving a 3-year term on ASHP’s Commission on Credentialing and became a Fellow of ASHP in 2022.
Olivia Berger, PharmD, BCPS is a Clinical Pharmacy Specialist in Pain and Palliative Care at Johns Hopkins Bayview Medical Center. She is a graduate of the University of Pittsburgh School of Pharmacy and subsequently completed her PGY1 at Carolinas Medical Center followed by a PGY2 in Pain Management and Palliative Care at The Johns Hopkins Hospital. She rounds with the Palliative Care Service and is the pharmacist resource for the Addiction Medicine Consult Service at JHBMC.
LISTEN ON
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ADVERTISEMENT